Immunological characterization of HM5023507, an orally active PI3Kδ/γ inhibitor

• Main Authors: Yu Cai (Author), Jun Yu (Author), Ping Ren (Author), Jianlin He (Author), Zhipeng Wu (Author), Kun Xiao (Author), Hong Jia (Author), Jian Wang (Author), Yang Sai (Author), Guangxiu Dai (Author), Xiong Li (Author), Weiguo Su (Author), Karen Ngo (Author), Glenda Castro (Author), Paul D. Acton (Author), Wai‐Ping Fung‐Leung (Author), James P. Edwards (Author), Jennifer Venable (Author), Tadimeti S. Rao (Author)
• Format: Book
• Published: Wiley, 2020-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Phosphoinositide 3‐kinases, delta (PI3Kδ) and gamma (PI3Kγ) are enriched in immune cells and regulate the development and function of innate and adaptive immunity. Dual PI3Kδγ inhibitors are considered high value targets for their potential to treat a variety of immune‐mediated diseases, bu...